ArticleNature communications2025
AI-powered SPOT imaging for enhanced myocardial scar detection and quantification.
Article in Nature communications, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Wideband black- and bright-blood late gadolinium enhancement imaging in patients with implantable cardiac devices at 1.5 T for improved visualization and localization of myocardial injury.European heart journal. Imaging methods and practice · 2026Article
- Clinical applications of co-registered myocardial T2 mapping and dual bright- and black-blood late gadolinium enhancement magnetic resonance imaging.European heart journal. Imaging methods and practice · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
25 authors.
Funding
Abstract
Cardiovascular disease is the leading global cause of death, underscoring the need for accurate assessment of myocardial injury. The current gold standard, bright-blood late gadolinium enhanced MRI, suffers from poor contrast at the blood-scar interface, reducing sensitivity for subendocardial scar detection and limiting reproducibility. Moreover, reliance on expert manual analysis makes interpretation labor-intensive and variable. Here, we present SPOT, a multi-spectral bright- and black-blood imaging sequence that provides unprecedented scar-to-blood contrast and clear anatomical detail. Integrated with an artificial intelligence (AI) framework for automated image analysis, SPOT enables rapid, fully automated, and operator-independent quantification of myocardial injury. Validated in simulations, animal infarct models, and patients with heart disease, this combined imaging-AI platform delivers accurate detection and quantification in a single acquisition. This innovation presents significant opportunities for earlier diagnosis and enhanced therapeutic management of ischemic heart disease, with potential applications in a wide spectrum of other clinical settings.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.